Torhild Warncke

  • Consultant neurologist
 

Publications 2018

Namer B, Schmidt D, Eberhardt E, Maroni M, Dorfmeister E, Kleggetveit IP, Kaluza L, Meents J, Gerlach A, Lin Z, Winterpacht A, Dragicevic E, Kohl Z, Schüttler J, Kurth I, Warncke T, Jorum E, Winner B, Lampert A (2018)
Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
EBioMedicine, 39, 401-408
DOI 10.1016/j.ebiom.2018.11.042, PubMed 30503201

Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
Acta Obstet Gynecol Scand, 98 (2), 240-249
DOI 10.1111/aogs.13477, PubMed 30289161

Publications 2016

Kongsgaard UE, Fischer K, Pedersen TE, Bukholm IR, Warncke T (2016)
Complaints to the Norwegian System of Patient Injury Compensation 2001-14 following nerve blockade
Tidsskr Nor Laegeforen, 136 (23-24), 1989-1992
DOI 10.4045/tidsskr.16.0368, PubMed 28004547

Publications 2014

Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
J Pain Symptom Manage, 48 (5), 852-62
DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940

Publications 2013

Jørum E, Warncke T, Ørstavik K (2013)
[Small-fibre neuropathy]
Tidsskr Nor Laegeforen, 133 (2), 179-83
DOI 10.4045/tidsskr.12.0160, PubMed 23344604

Publications 2012

Jørum E, Warncke T (2012)
[Treatment of chronic non-malignant pain]
Tidsskr Nor Laegeforen, 132 (22), 2474
DOI 10.4045/tidsskr.12.1246, PubMed 23338018

Publications 2003

Jørum E, Warncke T, Stubhaug A (2003)
Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo
Pain, 101 (3), 229-35
DOI 10.1016/s0304-3959(02)00122-7, PubMed 12583865

Publications 2000

Warncke T, Stubhaug A, Jørum E (2000)
Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man
Pain, 86 (3), 293-303
DOI 10.1016/s0304-3959(00)00260-8, PubMed 10812259

Publications 1997

Warncke T, Jørum E, Stubhaug A (1997)
Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action
Neurosci Lett, 227 (1), 1-4
DOI 10.1016/s0304-3940(97)00263-2, PubMed 9178844

Warncke T, Stubhaug A, Jørum E (1997)
Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo
Pain, 72 (1-2), 99-106
DOI 10.1016/s0304-3959(97)00006-7, PubMed 9272793

Publications 1996

Warncke T, Brennum J, ArendtNielsen L, Branebjerg PE (1996)
Effects of local and systemic ibuprofen on primary and secondary hyperalgesia in man
Curr. Ther. Res.-Clin. Exp., 57 (12), 937-949

Publications 1994

Warncke T, Breivik H, Vainio A (1994)
Treatment of cancer pain in Norway. A questionnaire study
Pain, 57 (1), 109-16
DOI 10.1016/0304-3959(94)90114-7, PubMed 8065787

Page visits: 4221